NLRP1 polymorphisms in patients with asbestos-associated mesothelioma
NLRP1 polymorphisms in patients with asbestos-associated mesothelioma
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
An increasing incidence of malignant mesothelioma (MM) cases in patients with low levels of asbestos exposure suggests the interference of alternative cofactors. SV40 infection was detected, as co-morbidity factor, only in 22% of asbestos-MM patients from a North-Eastern Italy area. An additional mechanism of injury related to asbestos exposure in...
Alternative Titles
Full title
NLRP1 polymorphisms in patients with asbestos-associated mesothelioma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_7b59c93fa38f4b0b8a69dde5ecc3fcd2
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7b59c93fa38f4b0b8a69dde5ecc3fcd2
Other Identifiers
ISSN
1750-9378
E-ISSN
1750-9378
DOI
10.1186/1750-9378-7-25
